Pharmacokinetic Drug–drug Interactions Between 1,4-Dihydropyridine Calcium Channel Blockers and Statins: Factors Determining Interaction Strength and Relevant Clinical Risk Management

Therapeutics and Clinical Risk Management
doi 10.2147/tcrm.s55512
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Proischemic Complications of Dihydropyridine Calcium Channel Blockers

Circulation
Cardiovascular MedicinePhysiologyCardiology
1991English

Pharmacokinetic Drug-Drug Interaction and Responsible Mechanism Between Memantine and Cimetidine

Pharmaceutics
Pharmaceutical Science
2018English

Pharmacokinetic Drug–drug Interaction Study Between Clindamycin and Cyclosporin in Rabbits

Journal of Applied Pharmaceutical Science
MedicineToxicologyPharmaceuticsPharmacology
2020English

Safety of Statins: Focus on Clinical Pharmacokinetics and Drug Interactions

Circulation
Cardiovascular MedicinePhysiologyCardiology
2004English

Drug Induced Autoimmunity Related Neutrophilic Dermatosis by Calcium Channel Blockers

SKIN The Journal of Cutaneous Medicine
2019English

Worsening of Rosacea in Patients Treated With Dihydropyridine Calcium Channel Blockers: A Clinical Observation

Hypertension Research
Internal MedicineCardiovascular MedicinePhysiologyCardiology
2011English

Relationship Between Drug Interactions and Drug-Related Negative Clinical Outcomes

Pharmacy Practice
Pharmaceutical SciencePharmacy
2009English

Calcium Channel Regulation in Vascular Smooth Muscle Cells: Synergistic Effects of Statins and Calcium Channel Blockers

International Journal of Cardiology
Cardiovascular MedicineCardiology
2010English

Clinically Relevant Drug-Drug Interactions in Oncology

British Journal of Clinical Pharmacology
Pharmacology
1998English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy